BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33963955)

  • 41. Cerebral small vessel disease caused by a novel heterozygous mutation in HTRA1.
    Thaler FS; Catak C; Einhäupl M; Müller S; Seelos K; Wollenweber FA; Kümpfel T
    J Neurol Sci; 2018 May; 388():19-21. PubMed ID: 29627020
    [No Abstract]   [Full Text] [Related]  

  • 42. Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation.
    Ito J; Nozaki H; Toyoshima Y; Abe T; Sato A; Hashidate H; Igarashi S; Onodera O; Takahashi H; Kakita A
    Neuropathology; 2018 May; ():. PubMed ID: 29797751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.
    Mancuso M; Arnold M; Bersano A; Burlina A; Chabriat H; Debette S; Enzinger C; Federico A; Filla A; Finsterer J; Hunt D; Lesnik Oberstein S; Tournier-Lasserve E; Markus HS
    Eur J Neurol; 2020 Jun; 27(6):909-927. PubMed ID: 32196841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CADASIL brain vessels show a HTRA1 loss-of-function profile.
    Zellner A; Scharrer E; Arzberger T; Oka C; Domenga-Denier V; Joutel A; Lichtenthaler SF; Müller SA; Dichgans M; Haffner C
    Acta Neuropathol; 2018 Jul; 136(1):111-125. PubMed ID: 29725820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased water exchange rate across blood-brain barrier in hereditary cerebral small vessel disease.
    Li Y; Ying Y; Yao T; Jia X; Liang H; Tang W; Jia X; Song H; Shao X; Wang DJJ; Wang C; Cheng X; Yang Q
    Brain; 2023 Jul; 146(7):3079-3087. PubMed ID: 36625892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.
    Khaleeli Z; Jaunmuktane Z; Beaufort N; Houlden H; Haffner C; Brandner S; Dichgans M; Werring D
    J Neurol; 2015 May; 262(5):1369-72. PubMed ID: 25957642
    [No Abstract]   [Full Text] [Related]  

  • 47. Systematic Review of Cerebral Phenotypes Associated With Monogenic Cerebral Small-Vessel Disease.
    Whittaker E; Thrippleton S; Chong LYW; Collins VG; Ferguson AC; Henshall DE; Lancastle E; Wilkinson T; Wilson B; Wilson K; Sudlow C; Wardlaw J; Rannikmäe K
    J Am Heart Assoc; 2022 Jun; 11(12):e025629. PubMed ID: 35699195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel mutation in the HTRA1 gene identified in Chinese CARASIL pedigree.
    Wang XL; Li CF; Guo HW; Cao BZ
    CNS Neurosci Ther; 2012 Oct; 18(10):867-9. PubMed ID: 22900900
    [No Abstract]   [Full Text] [Related]  

  • 49. Patients with heterozygous HTRA1-related cerebral small vessel disease misdiagnosed with other diseases: Two case reports.
    Kitahara S; Tsuboguchi S; Uemura M; Nozaki H; Kanazawa M; Onodera O
    Clin Neurol Neurosurg; 2022 Dec; 223():107502. PubMed ID: 36334553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel heterozygous HTRA1 mutation is associated with autosomal dominant hereditary cerebral small vessel disease.
    Zhuo ZL; Cong L; Zhang J; Zhao XT
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1111. PubMed ID: 32239807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monogenic causes of stroke: now and the future.
    Tan RY; Markus HS
    J Neurol; 2015 Dec; 262(12):2601-16. PubMed ID: 26037017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic.
    Coste T; Hervé D; Neau JP; Jouvent E; Ba F; Bergametti F; Lamy M; Cogez J; Derache N; Schneckenburger R; Grelet M; Gollion C; Lanotte L; Lauer V; Layet V; Urbanczyk C; Didic M; Raynouard I; Delaval L; Dassa J; Florea A; Badiu C; Nguyen K; Tournier-Lasserve E
    Brain; 2021 Oct; 144(9):2616-2624. PubMed ID: 34270682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two novel HTRA1 mutations in a European CARASIL patient.
    Bianchi S; Di Palma C; Gallus GN; Taglia I; Poggiani A; Rosini F; Rufa A; Muresanu DF; Cerase A; Dotti MT; Federico A
    Neurology; 2014 Mar; 82(10):898-900. PubMed ID: 24500651
    [No Abstract]   [Full Text] [Related]  

  • 54. Monogenic Causes of Strokes.
    Chojdak-Łukasiewicz J; Dziadkowiak E; Budrewicz S
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel In-Frame Deletion in
    Grigaitė J; Šiaurytė K; Audronytė E; Preikšaitienė E; Burnytė B; Pranckevičienė E; Ekkert A; Utkus A; Jatužis D
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary cerebral small vessel diseases: a review.
    Federico A; Di Donato I; Bianchi S; Di Palma C; Taglia I; Dotti MT
    J Neurol Sci; 2012 Nov; 322(1-2):25-30. PubMed ID: 22868088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.
    Kato T; Manabe RI; Igarashi H; Kametani F; Hirokawa S; Sekine Y; Fujita N; Saito S; Kawashima Y; Hatano Y; Ando S; Nozaki H; Sugai A; Uemura M; Fukunaga M; Sato T; Koyama A; Saito R; Sugie A; Toyoshima Y; Kawata H; Murayama S; Matsumoto M; Kakita A; Hasegawa M; Ihara M; Kanazawa M; Nishizawa M; Tsuji S; Onodera O
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects.
    Mishra A; Chauhan G; Violleau MH; Vojinovic D; Jian X; Bis JC; Li S; Saba Y; Grenier-Boley B; Yang Q; Bartz TM; Hofer E; Soumaré A; Peng F; Duperron MG; Foglio M; Mosley TH; Schmidt R; Psaty BM; Launer LJ; Boerwinkle E; Zhu Y; Mazoyer B; Lathrop M; Bellenguez C; Van Duijn CM; Ikram MA; Schmidt H; Longstreth WT; Fornage M; Seshadri S; Joutel A; Tzourio C; Debette S
    Brain; 2019 Apr; 142(4):1009-1023. PubMed ID: 30859180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1.
    Qian E; Uemura M; Kobayashi H; Nakamura S; Ozawa F; Yoshimatsu S; Ishikawa M; Onodera O; Morimoto S; Okano H
    Inflamm Regen; 2023 Apr; 43(1):23. PubMed ID: 37009886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterozygous Pathogenic and Likely Pathogenic Symptomatic
    Xu SY; Li HJ; Li S; Ren QQ; Liang JL; Li CX
    Int J Gen Med; 2023; 16():1149-1162. PubMed ID: 37016629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.